Emily King

Emily King is a Senior Scientist II in Bioinformatics at AbbVie, with extensive experience in target prioritization from GWAS and PheWAS datasets, as well as data integration and analysis for CRISPR and cell painting screens. Prior to this role, Emily served as a Postdoctoral Fellow in Computational Genomics, focusing on predicting drug targets from human genetic evidence through biomedical data integration and predictive modeling. Emily's academic background includes a PhD in Statistics and an MS in Statistics from Iowa State University, an MS in Geological and Earth Sciences from the University of Chicago, and a BS in Geological and Earth Sciences from the same institution. Professional experience includes roles as a Research Assistant and Instructor at Iowa State University and a Summer Intern in Biostatistics at Mayo Clinic, with contributions to publications and advancements in statistical methods for genomic research.